Critical Analysis: BioHarvest Sciences (BHST) & Its Rivals

BioHarvest Sciences (NASDAQ:BHST) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it compare to its competitors? We will compare BioHarvest Sciences to related businesses based on the strength of its valuation, profitability, earnings, institutional ownership, analyst recommendations, dividends and risk.

Analyst Recommendations

This is a summary of recent ratings and price targets for BioHarvest Sciences and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1	0	2	0	2.33
BioHarvest Sciences Competitors	904	2943	3663	229	2.42

BioHarvest Sciences presently has a consensus price target of $6.50, indicating a potential upside of 331.89%. As a group, “Personal Care Products” companies have a potential upside of 0.39%. Given BioHarvest Sciences’ higher possible upside, equities analysts clearly believe BioHarvest Sciences is more favorable than its competitors.

Risk & Volatility

BioHarvest Sciences has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, BioHarvest Sciences’ competitors have a beta of 0.80, indicating that their average stock price is 20% less volatile than the S&P 500.

Earnings and Valuation

This table compares BioHarvest Sciences and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
BioHarvest Sciences	$34.51 million	-$11.14 million	-2.89
BioHarvest Sciences Competitors	$8.28 billion	$1.11 billion	8.40

BioHarvest Sciences’ competitors have higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

48.6% of shares of all “Personal Care Products” companies are held by institutional investors. 11.7% of shares of all “Personal Care Products” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares BioHarvest Sciences and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
BioHarvest Sciences Competitors	-4.71%	-66.70%	-0.51%

Summary

BioHarvest Sciences competitors beat BioHarvest Sciences on 9 of the 13 factors compared.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc. is a biotechnology company developing health and wellness products through its proprietary Botanical Synthesis technology. The platform is designed to produce plant-based compounds in controlled environments without relying on conventional agricultural cultivation of the whole plant, with the goal of preserving targeted botanical molecules and improving production consistency. The company’s primary commercial product is VINIA, a dietary supplement made from a proprietary red grape cell culture and marketed for its polyphenol content and potential cardiovascular and general wellness benefits.